MedTrace Logo

Long-Term Outcomes of ABO-Incompatible Versus Compatible Living Donor Liver Transplantation

NCT07105085 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 511

Last updated 2025-08-05

No results posted yet for this study

Summary

This retrospective cohort study investigates the long-term outcomes of ABO-incompatible (ABO-I) versus ABO-compatible (ABO-C) living donor liver transplantation (LDLT). A total of 511 patients at a single high-volume transplant center in Korea.

The study aims to compare overall survival and the incidence of biliary complications.

Conditions

Interventions

PROCEDURE

living donor liver transplantation

other intervention cannot be applied.

Sponsors & Collaborators

  • Seoung Hoon Kim

    lead OTHER_GOV

Principal Investigators

  • Seoung Hoon kim, MD, PhD · National Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2022-12-31
Completion
2025-07-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07105085 on ClinicalTrials.gov